Caplin Point Laboratories Ltd's sterile product manufacturing subsidiary Caplin Steriles Ltd has received approval from the US Food and Drug Administration to market Thiamine Hydrochloride injection USP, the company said via an exchange filing.
The injection is a generic of Thiamine Hydrochloride injection of Fresenius Kabi USA LLC.
Thiamine Hydrochloride injection is used in the treatment of Thiamine, or Vitamin B1, deficiency and beriberi, a serious condition caused by a prolonged lack of Vitamin B1 in the body.
The Thiamine Hydrochloride injection had sales of $38 mln for the year ending September in the US, according to data by IQVIA.
Dhurandhar Box Office Collection Day 17: Ranveer Singh Starrer Beats Shah Rukh Khan's Pathaan & Ranbir Kapoor's Animal
Palghar: 30-Year-Old Labourer Stabbed To Death In Vasai; 28-Yr-Old Man Held
Uttar Pradesh Accident: 4 People Killed As Car Rams Into Dumper In Bijnor
Adani Bets Big On Aviation: Eyes Engine Repairs & Cargo Conversions
Shares of Caplin Point Laboratories traded 0.8% higher at ₹671.15 on NSE, at 11:15 IST.
